The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Pharmacology of nociceptin and its receptor: a novel therapeutic target
Open accessAbstract
Nociceptin (NC), alias Orphanin FQ, has been recently identified as the endogenous ligand of the opioid receptor‐like 1 receptor (OP 4). This new NC/OP 4 receptor system belongs to the opioid family and has been characterized pharmacologically with functional and binding assays on native (mouse, rat, guinea‐pig) and recombinant (human) receptors, by using specific and selective agonists (NC, NC(1–13)NH 2) and a pure and competitive antagonist, [Nphe 1]NC(1–13)NH 2. The similar order of potency of agonists and affinity values of the antagonist indicate that the same receptor is present in the four species. OP 4 is expressed in neurons, where it reduces activation of adenylyl cyclase and Ca 2+ channels while activating K+ channels in a manner similar to opioids. In this way, OP 4 mediates inhibitory effects in the autonomic nervous system, but its activities in the central nervous system can be either similar or opposite to those of opioids. In vivo experiments have demonstrated that NC modulates a variety of biological functions ranging from nociception to food intake, from memory processes to cardiovascular and renal functions, from spontaneous locomotor activity to gastrointestinal motility, from anxiety to the control of neurotransmitter release at peripheral and central sites. These actions have been demonstrated using NC and various pharmacological tools, as antisense oligonucleotides targeting OP 4 or the peptide precursor genes, antibodies against NC, an OP 4 receptor selective antagonist and with data obtained from animals in which the receptor or the peptide precursor genes were knocked out. These new advances have contributed to better understanding of the pathophysiological role of the NC/OP 4 system, and ultimately will help to identify the therapeutic potential of new OP 4 receptor ligands. British Journal of Pharmacology (2000) 129, 1261–1283; doi:10.1038/sj.bjp.0703219
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
Meunier, J.-C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.-L., Guillemot, J.-C., Ferrara, P., Monsarrat, B., et al. (1995) · Nature · doi:10.1038/377532a0 · Cited by 1,912
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor
Reinscheid, R. K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J., & Civelli, O. (1995) · Science · doi:10.1126/science.270.5237.792 · Cited by 1,821
A potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
Cloning of a Delta Opioid Receptor by Functional Expression
Evans, C. J., Keith, D. E., Morrison, H., Magendzo, K., & Edwards, R. H. (1992) · Science · doi:10.1126/science.1335167 · Cited by 1,233
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization
Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.-L., Moisand, C., Chalon, P., Caput, D., Vassart, G., & Meunier, J.-C. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80235-1 · Cited by 1,077
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Molecular cloning and functional expression of a mu opioid receptor from rat brain
Chen, Y., Mestek, A., Liu, J., Hurley, A., & Yu, L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90214-3 · Cited by 810
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
Mosberg, H. I., Hurst, R., Hruby, V. J., Gee, K., Yamamura, H. I., Galligan, J. J., & Burks, T. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.5871 · Cited by 740
International Union of Pharmacology. XII. Classification of opioid receptors
Dhawan, B., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P., Portoghese, P., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732
Paton, W. D. M. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01373.x · Cited by 641
Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands.
Li, C. H., & Chung, D. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1145 · Cited by 637
PATON, W. D. M. (1997) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1997.tb06787.x · Cited by 625
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., & Bell, G. I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6736 · Cited by 618
Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist
Portoghese, P. S., Sultana, M., & Takemori, A. E. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90502-x · Cited by 612
Bunzow, J. R., Saez, C., Mortrud, M., Bouvier, C., Williams, J. T., Low, M., & Grandy, D. K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00561-3 · Cited by 607
Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors
Handa, B. K., Lane, A. C., Lord, J. A. H., Morgan, B. A., Rance, M. J., & Smith, C. F. C. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90364-2 · Cited by 506
Bradford, H. F. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00030-5 · Cited by 449
Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor
Corbett, A. D., Paterson, S. J., McKnight, A. T., Magnan, J., & Kosterlitz, H. W. (1982) · Nature · doi:10.1038/299079a0 · Cited by 447
[3H]U-69593 a highly selective ligand for the opioid κ receptor
Lahti, R. A., Mickelson, M. M., McCall, J. M., & Von Voigtlander, P. F. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90431-5 · Cited by 444
cDNA cloning and regional distribution of a novel member of the opioid receptor family
Fukuda, K., Kato, S., Mori, K., Nishi, M., Takeshima, H., Iwabe, N., Miyata, T., Houtani, T., & Sugimoto, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80603-9 · Cited by 410
HUGHES, J., KOSTERLITZ, H. W., & LESLIE, F. M. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07373.x · Cited by 403
Neal, C. R., Mansour, A., Reinscheid, R., Nothacker, H.-P., Civelli, O., & Watson, S. J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990419)406:4<503::aid-cne7>3.0.co;2-p · Cited by 397
Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
Meunier, J.-C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01411-8 · Cited by 388
cDNA Cloning of an orphan opiate receptor gene family member and its splice variant
Wang, J. B., Johnson, P. S., Imai, Y., Persico, A. M., Ozenberger, B. A., Eppler, C. M., & Uhl, G. R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00557-5 · Cited by 381
Orphanin FQ is a functional anti-opioid peptide
Mogil, J. S., Grisel, J. E., Reinscheid, R. K., Civelli, O., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00338-7 · Cited by 375
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
Jenck, F., Moreau, J.-L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., Nothacker, H.-P., & Civelli, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14854 · Cited by 347
Chen, Y., Fan, Y., Liu, J., Mestek, A., Tian, M., Kozak, C. A., & Yu, L. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00560-5 · Cited by 333
The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQ
Henderson, G., & McKnight, A. T. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90645-3 · Cited by 331
Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors
Manabe, T., Noda, Y., Mamiya, T., Katagiri, H., Houtani, T., Nishi, M., Noda, T., Takahashi, T., Sugimoto, T., Nabeshima, T., et al. (1998) · Nature · doi:10.1038/29073 · Cited by 310
Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more
Darland, T., Heinricher, M. M., & Grandy, D. K. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01204-6 · Cited by 308
Opiate reward: Sites and substrates
Wise, R. A. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80021-1 · Cited by 287
Immunohistochemical localization of ORL-1 in the central nervous system of the rat
Anton, B., Fein, J., To, T., Li, X., Silberstein, L., & Evans, C. J. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960429)368:2<229::aid-cne5>3.0.co;2-5 · Cited by 287
Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene.
Mollereau, C., Simons, M. J., Soularue, P., Liners, F., Vassart, G., Meunier, J. C., & Parmentier, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8666 · Cited by 264
Nishi, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1858 · Cited by 261
Wick, M. J., Minnerath, S. R., Lin, X., Elde, R., Law, P.-Y., & Loh, H. H. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90181-3 · Cited by 256
Molecular Cloning of a Novel G Protein‐Coupled Receptor Related to the Opiate Receptor Family
Lachowicz, J. E., Shen, Y., Monsma, F. J., & Sibley, D. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010034.x · Cited by 256
Primary structure and tissue distribution of the orphanin FQ precursor.
Nothacker, H. P., Reinscheid, R. K., Mansour, A., Henningsen, R. A., Ardati, A., Monsma, F. J., Watson, S. J., & Civelli, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8677 · Cited by 253
Köster, A., Montkowski, A., Schulz, S., Stübe, E.-M., Knaudt, K., Jenck, F., Moreau, J.-L., Nothacker, H.-P., Civelli, O., & Reinscheid, R. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10444 · Cited by 247
Nociceptin/Orphanin FQ Microinjected into Hippocampus Impairs Spatial Learning in Rats
Sandin, J., Georgieva, J., Schött, P. A., Ögren, S. O., & Terenius, L. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01367.x · Cited by 244
Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
Chen, Y., Mestek, A., Liu, J., et al. (1993) · PubMed · Cited by 243
A new selective antagonist of the nociceptin receptor
Guerrini, R., Calo, G., Rizzi, A., Bigoni, R., Bianchi, C., Salvadori, S., & Regoli, D. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701640 · Cited by 238
Self-citationSchiller, P. W., Nguyen, T. M., Weltrowska, G., Wilkes, B. C., Marsden, B. J., Lemieux, C., & Chung, N. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11871 · Cited by 238
Portoghese, P. S. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90267-8 · Cited by 237
Tian, J., Xu, W., Fang, Y., Mogil, J. S., Grisel, J. E., Grandy, D. K., & Han, J. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700942 · Cited by 235
Nocistatin, a peptide that blocks nociceptin action in pain transmission
Okuda-Ashitaka, E., Minami, T., Tachibana, S., Yoshihara, Y., Nishiuchi, Y., Kimura, T., & Ito, S. (1998) · Nature · doi:10.1038/32660 · Cited by 233
Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ
Mogil, J. S., Grisel, J. E., Zhangs, G., Belknap, J. K., & Grandy, D. K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12917-7 · Cited by 227
Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro
Connor, M., Vaughan, C. W., Chieng, B., & Christie, M. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16080.x · Cited by 225
Xj, X., Hao, J. ‐., & Wiesenfeld‐Hallin, Z. (1996) · PubMed · Cited by 217
Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats
Pomonis, J. D., Billington, C. J., & Levine, A. S. (1996) · NeuroReport · doi:10.1097/00001756-199612200-00072 · Cited by 210
Structure-Activity Relationship Studies on the Novel Neuropeptide Orphanin FQ
Reinscheid, R. K., Ardati, A., Monsma, F. J., & Civelli, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14163 · Cited by 202
Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist
Calo', G., Guerrini, R., Bigoni, R., Rizzi, A., Marzola, G., Okawa, H., Bianchi, C., Lambert, D. G., Salvadori, S., & Regoli, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703169 · Cited by 190
Self-citationKnoflach, F., Reinscheid, R. K., Civelli, O., & Kemp, J. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06657.1996 · Cited by 181
Vaughan, C. W., Ingram, S. L., & Christie, M. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00996.1997 · Cited by 174
Murphy, N. P., Ly, H. T., & Maidment, N. T. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00322-3 · Cited by 173
Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis
Murphy, N. P., & Maidment, N. T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730179.x · Cited by 167
Jenkinson, D. H., Barnard, E. A., Hoyer, D., Humphrey, P. P., Leff, P., & Shankley, N. P. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06844-9 · Cited by 161
Dooley, C. T., Spaeth, C. G., Berzetei-Gurske, I. P., Craymer, K., Adapa, I. D., Brandt, S. R., Houghten, R. A., & Toll, L. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37095-8 · Cited by 160
Orphanin FQ/nociceptin blocks acquisition of morphine place preference
Murphy, N. P., Lee, Y., & Maidment, N. T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01425-0 · Cited by 158
Stratford, T. R., Holahan, M. R., & Kelley, A. E. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00009 · Cited by 149
Ueda, H., Yamaguchi, T., Tokuyama, S., Inoue, M., Nishi, M., & Takeshima, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00832-x · Cited by 147
The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion
Devine, D. P., Reinscheid, R. K., Monsma, F. J., Civelli, O., & Akil, H. (1996) · Brain Research · doi:10.1016/0006-8993(96)00476-3 · Cited by 145
Devine, D. P., Taylor, L. P., Reinscheid, R. K., Monsma, F. J., Civelli, O., & Akil, H. (1996) · Neurochemical Research · doi:10.1007/bf02532380 · Cited by 140
Nociceptin stimulates locomotion and exploratory behaviour in mice
Florin, S., Suaudeau, C., Meunier, J., & Costentin, J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00707-8 · Cited by 138
Peluso, J., LaForge, K. S., Matthes, H. W. D., et al. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00178-1 · Cited by 137
Characterization of nociceptin hyperalgesia and allodynia in conscious mice
Hara, N., Minami, T., Okuda‐Ashitaka, E., Sugimoto, T., Sakai, M., Onaka, M., Mori, H., Imanishi, T., Shingu, K., & Ito, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701146 · Cited by 137
Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide
Grisel, J. E., Mogil, J. S., Belknap, J. K., & Grandy, D. K. (1996) · Neuroreport · doi:10.1097/00001756-199609020-00012 · Cited by 136
Nishi, M., Takeshima, H., Mori, M., Nakagawara, K., & Takeuchi, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2814 · Cited by 133
Yamamoto, T., Nozaki‐Taguchi, N., & Kimura, S. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00166-8 · Cited by 133
Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo
Stanfa, L. C., Chapman, V., Kerr, N., & Dickenson, A. H. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15618.x · Cited by 132
Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices
Nicol, B., Lambert, D. G., Rowbotham, D. J., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16007.x · Cited by 130
Effect of nociceptin on alcohol intake in alcohol-preferring rats
Ciccocioppo, R., Panocka, I., Polidori, C., Regoli, D. C., & Massi, M. (1999) · Psychopharmacology · doi:10.1007/s002130050828 · Cited by 130
Self-citationSchulz, S., Schreff, M., Nü, D., Gramsch, C., & Höllt, V. (1996) · Neuroreport · doi:10.1097/00001756-199611250-00045 · Cited by 130
Hao, J., Xu, I. S., Wiesenfeld‐Hallin, Z., & Xu, X. (1998) · Pain · doi:10.1016/s0304-3959(98)00071-2 · Cited by 117
Nociceptin/Orphanin FQ Metabolism: Role of Aminopeptidase and Endopeptidase 24.15
Montiel-Hernández, J. L., Cornille, F., Roques, B. P., & Noble, F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010354.x · Cited by 115
Calò, G., Rizzi, A., Marzola, G., Guerrini, R., Salvadori, S., Beani, L., Regoli, D. C., & Bianchi, C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702087 · Cited by 114
Self-citationOrphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus
Yu, T., Fein, J. A., Phan, T., Evans, C. J., & Xie, C.-W. (1997) · Hippocampus · doi:10.1002/(sici)1098-1063(1997)7:1<88::aid-hipo9>3.0.co;2-3 · Cited by 113
Ikeda, K., Watanabe, M., Ichikawa, T., Kobayashi, T., Yano, R., & Kumanishi, T. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980914)399:1<139::aid-cne11>3.0.co;2-c · Cited by 113
Sim, L. J., & Childers, S. R. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971006)386:4<562::aid-cne4>3.0.co;2-0 · Cited by 113
Bimorphinans as highly selective, potent .kappa. opioid receptor antagonists
Portoghese, P. S., Lipkowski, A. W., & Takemori, A. E. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00385a002 · Cited by 112
Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ
Morgan, M. M., Grisel, J. E., Robbins, C. S., & Grandy, D. K. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00003 · Cited by 112
Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity.
Pelton, J. T., Gulya, K., Hruby, V. J., et al. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.236 · Cited by 110
Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites
Nicholson, J. R., Paterson, S. J., Menzies, J. R. W., Corbett, A. D., & McKnight, A. T. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-3-304 · Cited by 108
Giannuario, A. D., Pieretti, S., Catalani, A., & Loizzo, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00579-0 · Cited by 105
Circuitry Underlying AntiOpioid Actions of Orphanin FQ in the Rostral Ventromedial Medulla
Heinricher, M. M., McGaraughty, S., & Grandy, D. K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.6.3351 · Cited by 103
Orphanin FQ, a novel neuropeptide with anti-stress-like activity
Griebel, G., Perrault, G., & Sanger, D. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01684-4 · Cited by 100
Okuda‐Ashitaka, E., Tachibana, S., Houtani, T., Minami, T., Masu, Y., Nishi, M., Takeshima, H., Sugimoto, T., & Ito, S. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00165-9 · Cited by 100
Inoue, M., Shimohira, I., Yoshida, A., Zimmer, A., Takeshima, H., Sakurada, T., & Ueda, H. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35102-x · Cited by 100
Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat
Champion, H. C., & Kadowitz, P. J. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00087-8 · Cited by 96
Agonistic Effect of Buprenorphine in a Nociceptin/OFQ Receptor-Triggered Reporter Gene Assay
Wnendt, S., Krüger, T., Janocha, E., Hildebrandt, D., & Englberger, W. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.334 · Cited by 94
Seki, T., Awamura, S., Kimura, C., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00369-6 · Cited by 86
Loss of Antinociception Induced by Naloxone Benzoylhydrazone in Nociceptin Receptor-Knockout Mice
Noda, Y., Mamiya, T., Nabeshima, T., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18047 · Cited by 84
Polidori, C., Calo’, G., Ciccocioppo, R., Guerrini, R., Regoli, D. C., & Massi, M. (2000) · Psychopharmacology · doi:10.1007/s002130050073 · Cited by 81
Self-citationOkawa, H., Nicol, B., Bigoni, R., Hirst, R. A., Calò, G., Guerrini, R., Rowbotham, D. J., Smart, D., McKnight, A. T., & Lambert, D. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702539 · Cited by 78
Self-citationCardiovascular Effects of Nociceptin in Unanesthetized Mice
Madeddu, P., Salis, M. B., Milia, A. F., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.3.914 · Cited by 77
Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice
Hiramatsu, M., & Inoue, K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00003-5 · Cited by 77
Postsynaptic Mechanisms Underlying Responsiveness of Amygdaloid Neurons to Nociceptin/Orphanin FQ
Meis, S., & Pape, H.-C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08133.1998 · Cited by 76
Gümüşel, B., Hao, Q., Hyman, A. L., et al. (1997) · Life Sciences · doi:10.1016/s0024-3205(96)00696-0 · Cited by 76
Determination of activity for nociceptin in the mouse vas deferens
Berzetei‐Gurske, I. P., Schwartz, R. W., & Toll, L. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00238-5 · Cited by 75
Emmerson, P. J., & Miller, R. J. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0431t.x · Cited by 74
ORL-1 and Mu opioid receptor antisera label different fibers in areas involved in pain processing
Monteillet-Agius, G., Fein, J. A., Antón, B., & Evans, C. J. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980928)399:3<373::aid-cne6>3.0.co;2-y · Cited by 73
Involvement of endogenous Orphanin FQ in electroacupuncture-induced analgesia
Tian, J., Xu, W., Zhang, W., Fang, Y., Grisel, J. E., Mogil, J. S., Grandy, D. K., & Han, J.-S. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00024 · Cited by 72
Modulation of 5‐hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin
Sbrenna, S., Marti, M., Morari, M., Calò, G., Guerrini, R., Beani, L., & Bianchi, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703321 · Cited by 72
Self-citationYu, T., & Xie, C.-W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.3.1277 · Cited by 71
[Nphe1]nociceptin-(1–13)-NH2 antagonizes nociceptin effects in the mouse colon
Rizzi, A., Bigoni, R., Calò, G., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00730-x · Cited by 69
Self-citationAccelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats
Li, Y., Zhou, H., Chang, J.-K., & Han, J.-S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01337-2 · Cited by 67
Orphanin-FQ/Nociceptin (OFQ/N) Modulates the Activity of Suprachiasmatic Nucleus Neurons
Allen, C. N., Jiang, Z., Teshima, K., Darland, T., Ikeda, M., Nelson, C. S., Quigley, D. I., Yoshioka, T., Allen, R. G., Rea, M. A., et al. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02152.1999 · Cited by 66
Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats
Zhu, C.-B., Cao, X.-D., Xu, S.-F., & Wu, G.-C. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00704-0 · Cited by 66
Inhibitory effect of nociceptin on [3H]‐5‐HT release from rat cerebral cortex slices
Siniscalchi, A., Rodi, D., Beani, L., & Bianchi, C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702793 · Cited by 63
Peripheral and central actions of orphanin FQ (nociceptin) on murine colon
Osinski, M. A., Bass, P., & Gaumnitz, E. A. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.1.g125 · Cited by 63
Inhibition of nociceptin‐induced allodynia in conscious mice by prostaglandin D2
Minami, T., Okuda‐Ashitaka, E., Nishizawa, M., Mori, H., & Ito, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701421 · Cited by 59
Bertorelli, R., Corradini, L., Rafiq, K., Tupper, J., Calò, G., & Ongini, E. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702884 · Cited by 59
Pan, Y., Xu, J., Wan, B., Zuckerman, A., & Pasternak, G. W. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01039-4 · Cited by 58
Functional Blockade of Opioid Analgesia by Orphanin FQ/Nociceptin
King, M., Chang, A., & Pasternak, G. W. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00023-9 · Cited by 57
Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia
Leventhal, L., Mathis, J. P., Rossi, G. C., Pasternak, G. W., & Bodnar, R. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00272-6 · Cited by 56
Osinski, M. A., Pampusch, M. S., Murtaugh, M. P., & Brown, D. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00869-3 · Cited by 55
Reverse Physiology: Discovery of the Novel Neuropeptide, Orphanin FQ/Nociceptin
Civelli, O., Reinscheid, R. K., & Nothacker, H. (1998) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v12.i3.10 · Cited by 55
Maggi, C. A., Theodorsson, E., Santicioli, P., & Giuliani, S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90143-p · Cited by 55
The physiology and brain mechanisms of feeding
Rowland, N. E., Morien, A., & Li, B.-H. (1996) · Nutrition · doi:10.1016/s0899-9007(96)00227-4 · Cited by 52
CXII.—The morphine group. Part I. A discussion of the constitutional problem
Gulland, J. M., & Robinson, R. E. (1923) · Journal of the Chemical Society Transactions · doi:10.1039/ct9232300980 · Cited by 51
Analgesic activity of orphanin FQ2, murine prepro-orphanin FQ141-157 in mice.
Gc, R., Mathis, J. P., & Pasternak, G. (1998) · PubMed · Cited by 50
Nocistatin reverses nociceptin inhibition of glutamate release from rat brain slices
Nicol, B., Lambert, D. G., Rowbotham, D. J., Okuda‐Ashitaka, E., Ito, S., Smart, D., & McKnight, A. T. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00545-7 · Cited by 49
Modification of dopamine release by nociceptin in conscious rat striatum
Konya, H., Masuda, H., Itoh, K., Nagai, K., Kakishita, E., & Matsuoka, A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00075-4 · Cited by 48
Grisel, J. E., Farrier, D. E., Wilson, S. G., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00567-6 · Cited by 47
Sbrenna, S., Marti, M., Morari, M., et al. (1999) · PubMed · Cited by 44
Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens
Zhang, G., Murray, T. F., & Grandy, D. K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00858-5 · Cited by 44
Nociceptin fails to affect heroin self-administration in the rat
Walker, J. R., Spina, M. G., Terenius, L. Y., & Koob, G. F. (1998) · Neuroreport · doi:10.1097/00001756-199807130-00017 · Cited by 44
Nociceptin system plays a role in the memory retention
Mamiya, T., Noda, Y., Nishi, M., Takeshima, H., & Nabeshima, T. (1999) · Neuroreport · doi:10.1097/00001756-199904260-00003 · Cited by 44
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies
Varani, K., Rizzi, A., Calò, G., Bigoni, R., Tóth, G., Guerrini, R., Gessi, S., Salvadori, S., Borea, P. A., & Regoli, D. C. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900074 · Cited by 43
Self-citationWerthwein, S., Bauer, U. S., Nakazi, M., Kathmann, M., & Schlicker, E. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702534 · Cited by 37
Chiou, L. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702746 · Cited by 36
Nociceptin, a novel endogenous ligand for the ORL1 receptor, has potent erectile activity in the cat
Champion, H. C., Wang, R., Hellstrom, W. J. G., & Kadowitz, P. J. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.1.e214 · Cited by 36
Pronociceptive Effects of the Neuropeptide, Nociceptin, in the Land Snail, Cepaea nemoralis
Kavaliers, M., & Perrot-Sinal, T. S. (1996) · Peptides · doi:10.1016/0196-9781(96)00105-2 · Cited by 33
Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats
Nakagawa, T., Kaneko, M., Inamura, S., & Satoh, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00202-5 · Cited by 33
Orphanin FQ and Behavioral Sensitization to Cocaine
Narayanan, S., & Maidment, N. T. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00261-5 · Cited by 29
Anti‐nociceptive responses produced by human putative counterpart of nocistatin
Minami, T., Okuda‐Ashitaka, E., Nishiuchi, Y., Kimura, T., Tachibana, S., Mori, H., & Ito, S. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701995 · Cited by 29
Olianas, M. C., Maullu, C., Ingianni, A., et al. (1999) · Neuroreport · doi:10.1097/00001756-199904060-00041 · Cited by 28
Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus
Bregola, G., Candeletti, S., Romualdi, P., & Simonato, M. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00018 · Cited by 15
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Basic opioid pharmacology: an update
Pathan, H., & Williams, J. (2012) · British Journal of Pain · doi:10.1177/2049463712438493 · Cited by 671
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Pharmacology of Penile Erection
Andersson, K.-E. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01503-5 · Cited by 528
Metadata
- Authors
- Calo', G., Guerrini, R., Rizzi, A., Salvadori, S., & Regoli, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 129
- Issue
- 7
- Pages
- 1261-1283
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2014237020
- Cited by
- 437
- References
- 139
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.